NCT03678584View on ClinicalTrials.gov

Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 3, 2019

Conditions
Infertility
Interventions
OTHER

Medium Supplemented with Chaetoglobosin A

A medium with in-house supplementation of Chaetoglobosin A to decrease oocyte degeneration after ICSI and improve the survival rate

Trial Locations (3)

12345

IbnSina IVF Center, IbnSina Hospital, Sohag

123456

Qena Fertility Center, Qina

Unknown

Banon Assiut, Asyut

All Listed Sponsors
collaborator

Banoon IVF Center

OTHER

collaborator

Qena Fertility Center

UNKNOWN

lead

Ibn Sina Hospital

OTHER_GOV

NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) | Biotech Hunter | Biotech Hunter